Levalbuterol
Active substance: levalbuterol
SOLUTION · LEVALBUTEROL HYDROCHLORIDE 1.25 mg/3mL
United StatesActive
Marketing holder: Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LEVALBUTEROL HYDROCHLORIDE · 1.25 mg/3mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-30ba-77b3-9acd-24814adac622,01a1208c-30ed-79cf-98aa-0302bdbd038c,01a1208c-51a1-76f3-b30b-6142a891224e,01a1208c-9b2a-73b8-ac39-178262a7c6fc,01a1208c-fea6-7b68-92ed-e9da080586e3;count=36 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 81894-103
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- RESPIRATORY (INHALATION)
Sources
- product · openFDA NDC · 81894-103 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 81894-103 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 81894-103 · Verified 2026-10-09 · open in source